Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas-Reference-Cited by-同舟云学术

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas

Published:1991-01 Issue: Volume:2 Page:33-35
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fisher Richard I.,Longo Dan L.,DeVita Vincent T.,Hubbard Susan M.,Miller Thomas P.,Young Robert C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/2/suppl_1/33/536701/2-suppl_1-33.pdf

Reference11 articles.

1. Advanced diffuse histiocytic lymphoma, a potentially curable disease;DeVita;Lancet,1975

2. Southwest Oncology Group studies in diffuse large cell lymphoma: A subset analysis;Coltman,1988

3. Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy;Fisher;Ann Intern Med,1983

4. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclo-phosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): A 10-year experience in a single institution;Gaynor;J Clin Oncol,1985

5. Randomized trial of ProMACE-MOPP (day 1, day 8) vs ProMACE-CytaBOM in previously untreated, advanced stage, diffuse aggressive lymphomas (abstr);Fisher;Proc Am Soc Clin Oncol,1984

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Bleomycin and Cytosine Arabinoside Chemotherapy for Relapsed Canine Lymphoma;Journal of the American Animal Hospital Association;2018-05-01

2. Translation failure and medical reversal: Two sides to the same coin;European Journal of Cancer;2016-01

3. The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL);Annals of Oncology;2006-04

4. Nodale aggressive Non-Hodgkin-Lymphome;Kompendium Internistische Onkologie;2006

5. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma;Cancer;2005